This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
New indication for evolocumab in established atherosclerotic cardiovascular disease
Read more
New treatment option for ‘wake-up’ stroke patients
Read more
NICE approves Avonex® as treatment option for people with MS
Read more
Enhanced recovery programme enables patients to return home three days after major surgery
Read more
SMC approves licence for liver cancer treatment
Read more
Thousands of women miss routine breast screening appointment due to ‘computer error’
Read more
NICE recommendation gives three more treatment options for people with blood cancer
Read more
Study investigates the utility of Masimo SpHb® in post-operative RBC transfusion best practices
Read more
Masimo technologies in two abstracts presented at the 2018 Annual Meeting of the International Anesthesia Research Society
Read more
MedTech advisory on mandatory EU medical device regulation issued
Read more
Pricing revolution needed to make new cancer drugs available to all
Read more
Immune cells discovery could help transform vaccine development
Read more
Safeguarding children through connected information
Read more
Herzuma now available in Europe
Read more
NICE Final Appraisal Determination for guselkumab to treat moderate to severe plaque psoriasis
Read more
Artificial intelligence and the indispensable human in diagnostics
Read more
£18 million fund to tackle six biggest themes in brain tumour research launched
Read more
Page 123 of 201
« First
«
...
10
20
30
...
121
122
123
124
125
...
130
140
150
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: